Desperate to cope with the 52,000 women diagnosed with breast cancer in Russia
every year, a delegation from the Federal Medical Biological Agency (FMBA) spent
time at Jerusalem’s Hala-Rachel Nash Jerusalem Breast Clinic, Israel’s only
comprehensive freestanding facility for the diagnosis of breast
The senior delegation was led by Kaneva Elena Petrovna, the
deputy chief of FMBA’s department of the organization of medical care in Moscow.
It also included heads of hospital oncology departments and other high-ranking
professionals involved in breast cancer in Russia.
They said they wanted
to develop an optimal model for a regional program on breast cancer screening in
Russia’s small towns and were extremely impressed with what they saw in
Rabbi Michoel Sorotzkin, the founder and chairman of the nonprofit
clinic, presented the delegation with facts and figures about what the clinic
does: Over 150,000 women visited Hala since 1997 and half of those visits were
for early detection screening. In 2012 alone, some 18,987 women visited the
Sorotzkin said benefits from Hala’s comprehensive model and
screening program had a 31 percent higher detection rate, in comparison to
fragmented diagnostic models used elsewhere, and that unnecessary procedures for
healthy woman (false-positive) were reduced by 48 percent.
professionals said they wanted to develop an “optimal model of a regional breast
cancer screening program.”
They added that every year, breast cancer is
increasingly found in younger women – even those under the age of 40.
the model is successful, they said, it could be implemented in other Russian
The guests said that “due to the large numbers of women from all
segments of population who have been screened in [the Hala] institute over the
past decade, [its] excellent performance and reputation, [it is] a perfect
choice for being a model we wish to clone in Russia.
The group of
participants were very keen in examining [Hala’s] state of the art technological
equipment and receiving preliminary guidance from [the] physicians and
professionals as to implementation of a state wide screening
FMBA is responsible for organization of a specialized health
and epidemiological supervision and for medical and sanitary support of the
workers employed in the hazardous industries. They said they were “very
impressed” with what they saw at Hala and that the tour was “the highlight of
Dr. Natali Loubashevski, a senior breast imaging specialist
at Hala, presented data on its screening program, which is expected to lead to
an exchange of ideas and protocols.